Health and Fitness Health and Fitness
Mon, November 21, 2011
[ Mon, Nov 21st 2011 ] - Market Wire
Alnylam Presents Positive Preliminary Clinical Re .. Therapeutic for the Treatment of Transthyretin-Me
[ Mon, Nov 21st 2011 ] - Market Wire
Perceptive Informatics Global Survey Results Indi .. ndard Medical Imaging Metrics to Meet Study Miles
[ Mon, Nov 21st 2011 ] - Market Wire
PowerVerde Announces Binding Letter of Intent to .. tion Group, a Technology and Distribution Company
[ Mon, Nov 21st 2011 ] - Market Wire
Exelixis Announces Initiation of Phase 2 Investig .. antinib in Women with Hormone Receptor-Positive M
[ Mon, Nov 21st 2011 ] - Market Wire
Comprehensive Care Corporation Announces Nine Month Revenues Top $54 Million, up 212 Percent
Sun, November 20, 2011
[ Sun, Nov 20th 2011 ] - Market Wire
Valeant Pharmaceuticals Agrees to Acquire iNova
[ Sun, Nov 20th 2011 ] - Market Wire
CML HealthCare Inc. Declares November Dividend
Fri, November 18, 2011
[ Fri, Nov 18th 2011 ] - Market Wire
Warnex Reaches Agreement to Extend Maturity Date .. ing Debentures and to Obtain Additional Financing
[ Fri, Nov 18th 2011 ] - Market Wire
Quidel to Present at 23rd Annual Piper Jaffray Health Care Conference
[ Fri, Nov 18th 2011 ] - Market Wire
Regeneron Announces FDA Approval of EYLEAa" (afli .. Treatment of Wet Age-Related Macular Degeneration
[ Fri, Nov 18th 2011 ] - Market Wire
Cigna Announces Leadership Changes
[ Fri, Nov 18th 2011 ] - Market Wire
Orthofix International to Participate in the 23rd Annual Piper Jaffray Healthcare Conference
[ Fri, Nov 18th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates Chemed Corp.
[ Fri, Nov 18th 2011 ] - Market Wire
Steps in the Right Direction - Featured Research .. ign Technology, Inc. and IDEXX Laboratories, Inc.
[ Fri, Nov 18th 2011 ] - Market Wire
Tibet Pharmaceuticals Announces Availability of Third Quarter 2011 Earnings Call Transcript
[ Fri, Nov 18th 2011 ] - Market Wire
Daxor Corporation Announces Intention to Register .. Company Under the Investment Company Act of 1940
[ Fri, Nov 18th 2011 ] - Market Wire
Boston Scientific to Participate in 2011 Piper Jaffray 23rd Annual Healthcare Conference
[ Fri, Nov 18th 2011 ] - Market Wire
Poniard Pharmaceuticals Announces Licensing Agreement for Focal Adhesion Kinase Technology
[ Fri, Nov 18th 2011 ] - Market Wire
Zalicus and Oncothyreon -- Low Valuations Reawaken Investor Enthusiasm
[ Fri, Nov 18th 2011 ] - Market Wire
Low Valuations for Sequenom and Marina Biotech Shares Spark Investor Interest
[ Fri, Nov 18th 2011 ] - Market Wire
Equity Research on Lincare Holdings Inc. and Amedisys Inc. - Home Health Care Industry Struggling
[ Fri, Nov 18th 2011 ] - Market Wire
CALCOL to Advise TPG on China Beverage Deals
[ Fri, Nov 18th 2011 ] - Market Wire
ImmunoCellular Therapeutics to Present at the 16t .. Annual Meeting of the Society for Neuro-Oncology
[ Fri, Nov 18th 2011 ] - Market Wire
StockTradersTalk Interviews Micro Imaging Technology, Inc. Chairman and CEO, Michael Brennan
[ Fri, Nov 18th 2011 ] - Market Wire
Sirona Reports Record Fiscal 2011 Fourth Quarter and Full Year Results
[ Fri, Nov 18th 2011 ] - Market Wire
China Cord Blood Corporation to Report Second Qua .. r and First Half of Fiscal 2012 Financial Results
[ Fri, Nov 18th 2011 ] - Market Wire
Shire Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd.
Thu, November 17, 2011
[ Thu, Nov 17th 2011 ] - Market Wire
SurModics Completes Sale of Pharmaceutical Assets
[ Thu, Nov 17th 2011 ] - Market Wire
SciClone Pharmaceuticals Added to the NASDAQ Biotechnology Index
[ Thu, Nov 17th 2011 ] - Market Wire
Baxter to Present at the 23rd Annual Piper Jaffray Health Care Conference

Baxter to Present at the 23rd Annual Piper Jaffray Health Care Conference


Published on 2011-11-17 13:21:11 - Market Wire
  Print publication without navigation


DEERFIELD, Ill.--([ ])--Baxter International Inc. (NYSE: BAX) announced today that it will present at the 23rd Annual Piper Jaffray Health Care Conference on Tuesday, November 29, 2011, at 12:00 p.m. (CT) or 1:00 p.m. (ET).

The live webcast of Baxteras presentation can be accessed from the Baxter corporate website at [ www.baxter.com ] and will be available for replay through December 29, 2011.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Contributing Sources